Pelton, S. I., Mould-Quevedo, J. F., & Nguyen, V. H. (2024). Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US. Taylor & Francis Group.
Chicagoスタイル(17版)引用形式Pelton, Stephen I., Joaquin F. Mould-Quevedo, , Van Hung Nguyen. Modelling the Population-level Benefits and Cost-effectiveness of Cell-based Quadrivalent Influenza Vaccine for Children and Adolescents Aged 6 Months to 17 Years in the US. Taylor & Francis Group, 2024.
MLA(9版)引用形式Pelton, Stephen I., et al. Modelling the Population-level Benefits and Cost-effectiveness of Cell-based Quadrivalent Influenza Vaccine for Children and Adolescents Aged 6 Months to 17 Years in the US. Taylor & Francis Group, 2024.